Latest Breaking News On - Lungevity foundation - Page 2 : comparemela.com

'Landmark' Findings Led to Alecensa Approval for ALK-Positive NSCLC

Alecensa was shown to reduce the risk of disease recurrence or death by 76% versus chemotherapy for patients with ALK-positive non-small cell lung cancer.

Upal-basu-roy
Drug-administration
Lungevity-foundation
New-england-journal
Nsclc
Lung-cancer-treatment
Alecensa
Non-small-cell-lung-cancer

American Lung Association And Lungevity Foundation Announce $3 Million Research Partnership To Intercept Lung Cancer

American Lung Association And Lungevity Foundation Announce $3 Million Research Partnership To Intercept Lung Cancer
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Chicago
Illinois
United-states
Washington
Pennsylvania
Americans
American
Harold-wimmer
Andrea-ferris
Johnson
Avrum-spira
Steven-dubinett

IMFINZI® (durvalumab) significantly improved overall survival and progression-free survival for patients with limited-stage small cell lung cancer in ADRIATIC Phase III trial

First and only immunotherapy to demonstrate survival benefit in this setting in a global Phase III trial .

United-states
China
United-kingdom
Amsterdam
Noord-holland
Netherlands
Japan
Cambridge
Cambridgeshire
America
American
Suresh-senan

AstraZeneca : Imfinzi significantly improved overall survival and progression-free survival for patients with limited-stage small cell lung cancer in ADRIATIC Phase III trial - Form 6-K -April 05, 2024 at 06:26 am EDT

a4121j FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Issuer Pursuant to Rule 13a-16 or.

China
United-kingdom
Washington
United-states
Amsterdam
Noord-holland
Netherlands
Cambridge
Cambridgeshire
Japan
American
America

Chemo Shortage Didn't Materialize 'The Way We Initially Feared'

Chemo Shortage Didn't Materialize 'The Way We Initially Feared'
curetoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from curetoday.com Daily Mail and Mail on Sunday newspapers.

Amyc-moore
Lungevity-foundation